APA (7th ed.) Citation

RA, P., KS, B., W, H., T, T., L, P., K, M., . . . AA, S. (2014). A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy. Gynecologic oncology, 132(3), 531. https://doi.org/10.1016/j.ygyno.2014.01.036

Chicago Style (17th ed.) Citation

RA, Previs, et al. "A Prognostic Nomogram to Predict Overall Survival in Women with Recurrent Ovarian Cancer Treated with Bevacizumab and Chemotherapy." Gynecologic Oncology 132, no. 3 (2014): 531. https://doi.org/10.1016/j.ygyno.2014.01.036.

MLA (9th ed.) Citation

RA, Previs, et al. "A Prognostic Nomogram to Predict Overall Survival in Women with Recurrent Ovarian Cancer Treated with Bevacizumab and Chemotherapy." Gynecologic Oncology, vol. 132, no. 3, 2014, p. 531, https://doi.org/10.1016/j.ygyno.2014.01.036.